Boditech Med Inc. (206640)

Overview

Boditech Med Inc. is a leading provider of diagnostic solutions, operating both within South Korea and on an international scale. Since its establishment in 1998, the company has been at the forefront of innovation in the diagnostics field, developing advanced instruments and reagents for a wide range of diseases and health conditions. With a strong focus on research and development, Boditech Med Inc. is dedicated to improving patient outcomes through accurate and accessible diagnostic technologies. Headquartered in Chuncheon-si, South Korea, the company continues to expand its global footprint, offering solutions that address the needs of healthcare professionals and patients alike.

Products and Services

• ichroma II: A diagnostic immuno-analyzer designed to detect a variety of biomarkers for conditions such as cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases.
• ichroma III: This high-throughput immuno-analyzer enables simultaneous testing for various parameters, enhancing efficiency and diagnostic capabilities.
• ExAmplar: A compact real-time PCR device that quantitatively or qualitatively detects viruses/bacteria using easy-to-use cartridges.
• ichroma-50: An automated immunoassay system that offers high-throughput, suitable for laboratories with large sample volumes.
• Hemochroma PLUS: A handheld device designed for anemia testing, offering quick and reliable results in various settings.
• ichroma M3 and ichroma M2: Portable analyzers that provide flexibility and mobility for diagnostics, catering to different healthcare environments.
• NuActor: An automated system for extracting nucleic acids, streamlining the preparation process for molecular diagnostics.
• AFIAS series (AFIAS-1, AFIAS-3, AFIAS-6, and AFIAS-10): Compact immunoassay analyzers that suit various laboratory sizes and testing needs, with the capability to handle a range from single to multiple analyses simultaneously.
• Diagnostic Reagents: A wide range of reagents including those for cardiac conditions, cancer, COVID-19, hormones, infections, autoimmune diseases, organ functions, molecular diagnostics, therapeutic drug monitoring, and more, supporting a comprehensive diagnostic portfolio.
• Ichroma TRIAS: Offers ultra-high sensitivity for respiratory disease diagnostics, providing critical support during pandemic outbreaks and seasonal infections.
• ALFIAS-3: Another innovative diagnostic equipment geared towards enhancing accuracy and reliability in patient testing.
• SyncNeb: Although not detailed, this product complements the comprehensive range of diagnostic solutions offered by Boditech Med Inc.